Coromandel International Management Guidance Tracker
12 forward-looking guidance items tracked across 3 quarters.
Capex
Mechanical completion expected in December 2025, trial runs in January, commercial production by mid-January. Plant will generate power for entire complex and reduce cost profile.
Q3 FY26Backward integration projects at Kakinada to commission this quarterActiveThe sulfuric acid and phosphoric acid plants at Kakinada are progressing as per timelines and will be commissioned during Q4 FY26.
Q3 FY26Granulation train expansion to commission in Q3 FY27TrackedThe granulation train expansion is on track and will be commissioned in the third quarter of FY27.
Expansion
Project progressing well; will support volume growth in northern and central India.
Q4 FY26Granulation capacity expansion commissioning by December 2026TrackedProject to expand granulation capacity is on track for commissioning by December of this financial year.
Growth
Driven by new product launches, territory expansion, and co-marketing agreements. Targeting ₹1,000 crore revenue for formulation business.
Q3 FY26Crop protection domestic B2C growth target of 20-25% annuallyTrackedManagement aims to grow the domestic branded formulation business by 20-25% year-on-year, supported by new product launches and market expansion.
Q4 FY26Crop protection revenue growth 20-25% in FY27ActiveDriven by new product launches (6 new products), capacity expansion for key molecule, and aggressive domestic formulation growth.
Q4 FY26Senegal mine output to increase 30-40% in FY27TrackedPlanned volume increase from 3.5 lakh tons to support backward integration.
Margins
Management confident of sustaining this level despite raw material volatility.
Q3 FY26Fertilizer EBITDA margin target of ₹5,000-5,500/ton annualizedTrackedManagement reiterated the annualized EBITDA margin target of ₹5,000-5,500 per ton for the fertilizer business, despite near-term pressure from higher sulfur prices and currency depreciation.
Q4 FY26Crop protection consolidated EBITDA margin to stabilize at 9-10%TrackedNACL integration and product portfolio changes expected to improve margins from current 6-7%.